US FDA approves Johnson & Johnson's drug for immune-mediated disorder
The US FDA has approved Johnson & Johnson’s drug to treat patients aged 12 years and older with an immune-mediated disorder Source link
us fda
Read More
Aurobindo Pharma arm’s New Jersey warehouse gets OAI status after U.S. FDA inspectionÂ
Representational image of Aurobindo Pharma’s Unit IX in Andhra Pradesh | Photo Credit: A. Roy Chowdhury The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted. Such a classification means regulatory and/or administrative actions are…